Annotation Detail

Information
Associated Genes
NRG1
Associated Variants
NRG1 EXPRESSION
NRG1 EXPRESSION
Associated Disease
head and neck squamous cell carcinoma
Source Database
CIViC Evidence
Description
In non-HER2 amplified cell lines, sensitivity to HER2 kinase inhibitor lapatinib was found mainly in cell-lines with elevated NRG1 expression and HER3 activation. This aberration was mainly identified in head and neck cancer cell lines.
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/776
Gene URL
https://civic.genome.wustl.edu/links/genes/2593
Variant URL
https://civic.genome.wustl.edu/links/variants/314
Rating
4
Evidence Type
Predictive
Disease
Head And Neck Squamous Cell Carcinoma
Evidence Direction
Supports
Drug
Lapatinib
Evidence Level
D
Clinical Significance
Sensitivity/Response
Pubmed
21840482
Drugs
Drug NameSensitivitySupported
LapatinibSensitivitytrue